VYGR Voyager Therapeutics Inc
Company Analysis
Latest News
🔴 Voyager Therapeutics is trading 5.23% down today after no clear company-specific announcement was identified
Voyager Therapeutics is trading 5.23% down now at $3.35, after no clear company-specific announcement was identified for August 31, 2026. - The...
🟢 Voyager Therapeutics is trading 5.78% up today in pre-market
Voyager Therapeutics is trading 5.78% up at $3.66, with no clear company-specific catalyst identified for August 28, 2026. - Latest identifiable company...
🔴 Voyager Therapeutics falls 5.4% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🟢 Voyager Therapeutics rises 5.5% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🔴 Voyager Therapeutics is trading 5.36% down in pre-market
Voyager Therapeutics is trading 5.36% down at $3.00, versus its August 10 closing price of $3.17; no clear overnight catalyst was identified. - No new August...
Voyager Therapeutics second quarter 2026 loss narrows to $0.40 per share with $149M cash
Voyager Therapeutics reported a narrowed net loss of $24.5 million for the second quarter of 2026, primarily driven by a 30% reduction in research and...
Voyager Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Voyager Therapeutics is expected to report Q2 2026 revenue of $4.52 million and an EPS loss of $0.55, with its $3.12 share price currently trading...
🟢 Voyager Therapeutics is trading 5.2% up today in a pre-market rebound with no clear catalyst
Voyager Therapeutics is trading at $3.25 (5.2% up) in pre-market, rebounding from several mixed sessions over the past week despite a lack of fresh...
🟢 Voyager Therapeutics is trading 5.25% up today amid broader biotech sector strength
Voyager Therapeutics is trading at $3.21 (+5.25%) in pre-market sessions as the stock gains momentum despite a lack of fresh company-specific announcements. •...
🔴 Voyager Therapeutics is trading 5.5% down today as risk-off sentiment hits biotech sector
Voyager Therapeutics is trading 5.5% down at $3.02 as risk-off sentiment pressures the biotech sector and broader markets. • The decline extends a multi-day...
Voyager Presents Favorable Preclinical Data for Alzheimer's Gene Therapy Candidate VY1706
Voyager Therapeutics announced positive good laboratory practice (GLP) toxicology data for VY1706, its investigational tau silencing gene therapy for...
🔴 Voyager Therapeutics is trading 5.2% down today as risk-off sentiment pressures the biotech sector
Voyager Therapeutics is trading 5.2% down at $3.26 as risk-off sentiment hits the biotech sector, extending a multi-session slide from recent highs. • The...
🔴 Voyager Therapeutics is trading 5.4% down today with no clear catalyst
Voyager Therapeutics is trading 5.4% down at $3.48 amid light company news flow and a generally mixed broader market backdrop. • The stock's move appears tied...
🟢 VYGR is trading 5.3% up today following recent FDA IND clearance for VY1706 and upcoming AAIC presentation
• Voyager Therapeutics (VYGR) is trading 5.3% up today at $3.81. • The company recently received FDA Investigational New Drug (IND) clearance for VY1706, its...